Roche’s bispecific antibody, Columvi receives European approval for diffuse large B-cell lymphoma after initial therapy: Basel Tuesday, April 15, 2025, 10:00 Hrs [IST] Roche ann ...

The European Commission has approved Roche's Columvi as the first bispecific antibody for the treatment of diffuse large ...

Roche RHHBY announced that the European Commission has approved its lymphoma drug, Columvi (glofitamab), for second-line ...

Roche has secured approval from the European Commission (EC) for Columvi (glofitamab) plus gemcitabine and oxaliplatin (GemOx ...

Basel: Roche has announced that the company has received approval from the European Commission for Columvi (glofitamab) in ...

In this interview, Magdalena Corona de Lapuerta, recipient of the Jian-Jian Luan Award for Lymphoma Transplant Research, ...

Roche (RHHBY) announced that the European Commission, EC, has approved Columvi in combination with gemcitabine and oxaliplatin for the ...

Lucas Pacheco, a 18-year-old lymphoma survivor, fulfilled his dream of attending The Masters through the 'Make-A-Wish' ...

Limited’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Adolescent and Young Adult Cancer Awareness Week serves as an opportunity to shed light on the special considerations and experiences of younger oncology patient populations.

The band’s singer and bassist recounts his personal struggles and the dramatic ins and outs of the trio’s history in a new ...

Women in Lymphoma (WiL), which started as a small group of passionate women lymphoma investigators, has now grown into an ...